IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Pilotto, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.639
AS - Asia 4.560
EU - Europa 3.023
SA - Sud America 1.322
AF - Africa 113
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.670
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.471
SG - Singapore 1.808
CN - Cina 1.204
BR - Brasile 1.129
HK - Hong Kong 652
IT - Italia 567
DE - Germania 543
UA - Ucraina 408
FR - Francia 309
VN - Vietnam 295
GB - Regno Unito 244
FI - Finlandia 223
RU - Federazione Russa 215
TR - Turchia 187
IE - Irlanda 166
BD - Bangladesh 102
IN - India 83
CA - Canada 78
AR - Argentina 70
NL - Olanda 59
MX - Messico 57
CZ - Repubblica Ceca 56
PL - Polonia 53
ZA - Sudafrica 50
ID - Indonesia 44
AT - Austria 43
SE - Svezia 35
IQ - Iraq 34
EC - Ecuador 33
ES - Italia 33
CO - Colombia 27
JP - Giappone 26
SA - Arabia Saudita 23
BE - Belgio 18
VE - Venezuela 17
MA - Marocco 16
KE - Kenya 13
CL - Cile 12
EG - Egitto 12
LT - Lituania 11
PY - Paraguay 11
AZ - Azerbaigian 10
PK - Pakistan 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
JO - Giordania 8
KZ - Kazakistan 8
UY - Uruguay 8
AU - Australia 7
DO - Repubblica Dominicana 7
NP - Nepal 7
PT - Portogallo 7
CH - Svizzera 6
PE - Perù 6
BO - Bolivia 5
CR - Costa Rica 5
DZ - Algeria 5
IL - Israele 5
IR - Iran 5
PA - Panama 5
PH - Filippine 5
EU - Europa 4
LB - Libano 4
LV - Lettonia 4
PS - Palestinian Territory 4
AL - Albania 3
BB - Barbados 3
BG - Bulgaria 3
ET - Etiopia 3
GY - Guiana 3
JM - Giamaica 3
OM - Oman 3
RO - Romania 3
SN - Senegal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
CI - Costa d'Avorio 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
GD - Grenada 1
GT - Guatemala 1
Totale 16.663
Salva come PNG Salva come JPEG
Città #
Fairfield 884
Singapore 773
Ashburn 712
Hong Kong 649
Woodbridge 575
Houston 394
Seattle 384
Cambridge 327
Jacksonville 317
Beijing 306
Wilmington 296
Ann Arbor 262
New York 246
Princeton 236
Los Angeles 209
Chandler 189
Istanbul 168
Munich 149
Dublin 147
Helsinki 122
Chicago 112
The Dalles 110
Buffalo 108
Ho Chi Minh City 106
Dearborn 97
Des Moines 97
Nanjing 94
São Paulo 92
Brescia 88
Redondo Beach 88
Dallas 87
Milan 76
Moscow 72
San Diego 71
Hanoi 60
Nuremberg 58
Turku 57
San Francisco 55
London 52
Warsaw 51
Shenyang 50
Changsha 43
Shanghai 40
Santa Clara 38
Nanchang 37
Salt Lake City 37
Brno 33
Belo Horizonte 30
Rio de Janeiro 30
Frankfurt am Main 29
Lappeenranta 29
Boardman 28
Jinan 26
Montreal 26
Guangzhou 25
Lancaster 25
Tampa 25
Toronto 25
Brooklyn 24
Johannesburg 23
Ningbo 23
Orem 23
Tianjin 23
Vienna 23
Atlanta 22
Chennai 21
Hebei 21
Romola 21
Stockholm 21
Tokyo 21
Brasília 20
Olomouc 20
Brussels 18
Elk Grove Village 18
Norwalk 18
Phoenix 18
Denver 17
Dhaka 17
Guarulhos 17
Poplar 17
Zhengzhou 17
Düsseldorf 16
Kunming 16
Verona 16
Porto Alegre 15
Quito 15
Rome 15
Da Nang 14
Hangzhou 14
Mexico City 14
Boston 13
Charlotte 13
Jakarta 13
Jiaxing 12
Kilburn 12
Kyiv 12
Sterling 12
Campinas 11
Cape Town 11
Fortaleza 11
Totale 10.270
Salva come PNG Salva come JPEG
Nome #
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 263
COVID-19 impact on consecutive neurological patients admitted to the emergency department 209
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 206
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 202
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 199
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 180
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 172
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 168
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 165
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 165
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases 162
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 161
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 160
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 159
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts 158
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 154
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 152
Vascular risk factors and cognition in Parkinson's disease 152
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 149
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 149
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 147
Association between cognitive impairment and urinary dysfunction in Parkinson’s disease 144
Microarray gene and miRNA expression studies: Looking for new therapeutic targets for frontotemporal lobar degeneration 143
A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack 142
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 138
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 135
Reply to the Letter " Covid-19-associated encephalopathy and cytokine-mediated Neuroinflammation" 135
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 134
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 133
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria 133
Central serous chorioretinopathy: Pathogenesis and management 128
GBA-associated parkinsonism and dementia: Beyond α-synucleinopathies? 127
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs 127
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 127
Verbal memory declines more in female patients with Parkinson's disease: The importance of gender-corrected normative data 126
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 125
Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study 125
Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. 124
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementia. 124
Autonomic dysfunction in subjects at high risk for Parkinson’s disease 123
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 123
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia. 121
Disease-modifying therapies in frontotemporal lobar degeneration. 119
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 119
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles 119
Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism 117
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody 116
Pharmacogenetics of cytochrome P450 (CYP) in the elderly 116
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 114
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease 114
Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism 114
Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? 112
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with parkinson's disease 111
Erratum: Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (Neuron (2016) 91(1) (56–66)(S0896627316301970)(10.1016/j.neuron.2016.05.018)) 109
Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease 106
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 105
Brain glucose metabolism in Lewy body dementia: Implications for diagnostic criteria 102
Metabolic patterns across core features in dementia with lewy bodies 99
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 99
Brain-area specific white matter hyperintensities: Associations to falls in Parkinson's disease 98
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 98
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 97
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 97
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 97
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 97
Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients 96
Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum 95
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 92
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 92
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 91
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 90
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension 89
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 89
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 89
Struktureller Ultraschall des medialen Temporallappens bei Alzheimer-Demenz 87
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 86
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 86
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 83
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 83
The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications 82
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 82
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 82
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 82
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 81
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 79
Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer's Disease and Frontotemporal Lobar Degeneration Due to C9orf72 Repeat Expansions 77
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 77
null 77
Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson's disease 76
Dopaminergic deficits along the spectrum of Alzheimer’s disease 76
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 74
Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies 74
A multicentre validation study of the diagnostic value of plasma neurofilament light 74
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases 74
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 73
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study 73
Association of Plasma p-tau181 and p-tau231 Concentrations with Cognitive Decline in Patients with Probable Dementia with Lewy Bodies 71
Neurological disorders throughout acute SARS-CoV2 infection: A comparative study between vaccinated and non-vaccinated patients 71
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 70
Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis 69
Totale 11.686
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.137 0 0 0 0 0 261 117 148 162 200 152 97
2021/2022992 98 120 36 54 35 57 45 76 58 90 83 240
2022/2023794 135 23 9 27 74 216 12 63 115 16 54 50
2023/20241.220 80 20 105 61 58 231 47 42 295 23 48 210
2024/20254.065 56 26 47 515 394 261 264 177 488 393 945 499
2025/20264.681 794 1.114 724 1.234 720 95 0 0 0 0 0 0
Totale 16.972